跳至主要内容
临床试验/CTRI/2024/11/076104
CTRI/2024/11/076104尚未招募不适用

Comparison of fixed dose combination of Tramadol/Acetaminophen VS Codeine/Acetaminophen for management of mild-moderate pain in patients diagnosed with lung carcinoma - A Randomised Double Blinded Controlled Trial

BASAVATRARAKAM INDO AMERICAN CANCER HOSPITAL AND RESEARCH INSTITUTE1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年11月5日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Adequate pain relief of more than or equal to 60 percentage with the initiation of fixed dose combination of drugs

研究概览

简要总结

This is a randomized , double blinded parallel group single-centre trail comparing fixed dose combination of tramadol/acetaminophen vs Codeine/ Acetaminophen for management of mild-moderate pain in patients with lung carcinoma. The primary outcome is 60 percentage or more pain relief with initiation of fixed dose combination, assessed at 1 st day , 7th day and 14th day.  The secondary outcome is to assess the side effect profile at the same time periods.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Adult who are aged more than 18 years who have lung cancer irrespective of the stage who consent for the study.
  • Pain score should be less than 7 in NRS and the patient should have no cognitive impairment.

排除标准

  • Patients with cancer whose age is less than 18 and those with lung cancer who do not consent for the study.
  • Previous opioid users will be excluded.

结局指标

主要结局

Adequate pain relief of more than or equal to 60 percentage with the initiation of fixed dose combination of drugs

时间窗: The patients will be interviewed after the first day and on the 7th day and then on the 14th day of drug initiation

次要结局

  • SIDE EFFECT ASSESSMENT(DAY ONE. DAY 7, DAY 14)

研究者

发起方
BASAVATRARAKAM INDO AMERICAN CANCER HOSPITAL AND RESEARCH INSTITUTE
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

SHARUN MATHEW JOHN

BASAVATARAKAM INDO AMERICAN CANCER HOSPITAL AND RESEARCH INSTITUTE

研究点 (1)

Loading locations...

相似试验